Full Text
CO109 Evaluating the Lifetime Incremental Value of Pharmaceutical Innovation: The Case of Non-Small Cell Lung Cancer

Abstract

Authors

Panagiotis Therianos Aurelio Miracolo Jennifer Gill Panos Kanavos

Back to Volume 28, Supplemental Issue 12S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×